Zepp Health Corporation (ZEPP) — Analyst outlook / Analyst consensus target is.
The consensus price target is $12.00, representing a downside of 15% from the current price $14.12.
Analysts estimate Earnings Per Share (EPS) of $-0.22 and revenue of $0.19B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-18.56 vs est $-0.22 (missed -8176.8%). 2025: actual $-283.04 vs est $-0.11 (missed -251418.5%). Analyst accuracy: 1%.
ZEPP Stock — 12-Month Price Forecast
$12.00
▼ -15.01% Downside
Average Price Target
Based on 0 Wall Street analysts offering 12-month price targets for Zepp Health Corporation, the price target is $12.00.
The average price target represents a -15.01% change from the last price of $14.12.
EPS Estimates — ZEPP
1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$18.56
vs Est –$0.22
▼ 98.8% off
2025
Actual –$283.04
vs Est –$0.11
▼ 100.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — ZEPP
55%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.183B
vs Est $0.190B
▼ 4.0% off
2025
Actual $1.815B
vs Est $0.265B
▲ 85.4% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
